Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.81 |
---|---|
High | 4.11 |
Low | 3.75 |
Bid | 3.81 |
Offer | 4.15 |
Previous close | 3.76 |
Average volume | 744.93k |
---|---|
Shares outstanding | 97.93m |
Free float | 88.12m |
P/E (TTM) | -- |
Market cap | 368.23m USD |
EPS (TTM) | -1.71 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
- Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital
- Alector Reports Third Quarter 2024 Financial Results and Provides Business Update
- Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
- Alector to Participate in Upcoming Healthcare Conferences
- Alector Reports Second Quarter 2024 Financial Results and Provides Business Update
- Alector to Host Mid-Year Earnings Conference Call
- Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)
- Alector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Conference® (AAIC®) 2024
- Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
- Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform
More ▼